PL1894576T3 - Nowy środek do obniżania poziomu triglicerydów - Google Patents

Nowy środek do obniżania poziomu triglicerydów

Info

Publication number
PL1894576T3
PL1894576T3 PL06756590T PL06756590T PL1894576T3 PL 1894576 T3 PL1894576 T3 PL 1894576T3 PL 06756590 T PL06756590 T PL 06756590T PL 06756590 T PL06756590 T PL 06756590T PL 1894576 T3 PL1894576 T3 PL 1894576T3
Authority
PL
Poland
Prior art keywords
reducing agent
triglyceride reducing
novel triglyceride
novel
agent
Prior art date
Application number
PL06756590T
Other languages
English (en)
Inventor
Toru Yokoyama
Taro Aoki
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co filed Critical Kowa Co
Publication of PL1894576T3 publication Critical patent/PL1894576T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
PL06756590T 2005-06-08 2006-05-25 Nowy środek do obniżania poziomu triglicerydów PL1894576T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68837905P 2005-06-08 2005-06-08
EP06756590A EP1894576B1 (en) 2005-06-08 2006-05-25 Novel triglyceride reducing agent
PCT/JP2006/310440 WO2006132091A1 (ja) 2005-06-08 2006-05-25 新規なトリグリセリド低下剤

Publications (1)

Publication Number Publication Date
PL1894576T3 true PL1894576T3 (pl) 2011-10-31

Family

ID=37498294

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06756590T PL1894576T3 (pl) 2005-06-08 2006-05-25 Nowy środek do obniżania poziomu triglicerydów

Country Status (10)

Country Link
US (2) US20090227610A1 (pl)
EP (1) EP1894576B1 (pl)
JP (1) JP4892477B2 (pl)
KR (1) KR101258422B1 (pl)
CN (1) CN101193656B (pl)
CY (1) CY1111768T1 (pl)
ES (1) ES2362534T3 (pl)
PL (1) PL1894576T3 (pl)
PT (1) PT1894576E (pl)
WO (1) WO2006132091A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1942895E (pt) 2005-09-15 2012-03-29 Otsuka Pharma Co Ltd Fármaco de combinação contendo probucol e um derivado de tetrazolilalcoxi-di-hidrocarboestirilo com efeitos supressores de superóxido
UA106422C2 (uk) 2006-07-05 2014-08-26 Такеда Гмбх КОМБІНОВАНЕ ЗАСТОСУВАННЯ ІНГІБІТОРА PDE4 ТА ІНГІБІТОРА HMG-CоA-РЕДУКТАЗИ ДЛЯ ПРОФІЛАКТИКИ АБО ЗЦІЛЮВАЛЬНОГО ЛІКУВАННЯ ЗАПАЛЬНОГО ЗАХВОРЮВАННЯ ЛЕГЕНІВ
US20120108651A1 (en) * 2010-11-02 2012-05-03 Leiden University Medical Center (LUMC) Acting on Behalf of Academic Hospital Leiden (AZL) Genetic polymorphisms associated with venous thrombosis and statin response, methods of detection and uses thereof
CN105407884B (zh) * 2013-07-25 2019-04-30 美迪诺亚公司 降低甘油三酯、总胆固醇和低密度脂蛋白血液浓度的方法
KR101920307B1 (ko) * 2017-04-28 2018-11-20 가톨릭대학교 산학협력단 고정용량의 실로스타졸 서방출 및 스타틴 일반방출 미니정제를 포함하는 1일 1회 경구복용 복합 캡슐제 및 이의 제조방법
CN113316469A (zh) * 2019-03-13 2021-08-27 国立大学法人浜松医科大学 主动脉瘤的治疗用医药组合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW338037B (en) * 1995-10-05 1998-08-11 Otsuka Pharma Co Ltd Carbostyril derivatives possessing platelet aggregation inhibitory activity, antithrombotic activity, intima thinkening, inhibitory activity and phosphoriesterase inhibitory activity, their preparation and pharmaceutical composition
JP2964029B2 (ja) * 1995-10-05 1999-10-18 大塚製薬株式会社 カルボスチリル誘導体
AU2404897A (en) * 1996-04-24 1997-11-12 Takeda Chemical Industries Ltd. Fused imidazopyridine derivatives as antihyperlipidemic agents
US20020055533A1 (en) * 2000-09-01 2002-05-09 Sankyo Company, Limited Pharmaceutical composition
US20030114469A1 (en) * 2001-09-27 2003-06-19 Cohen David Saul Combinations
AU2003245313A1 (en) * 2002-06-10 2003-12-22 Elan Pharma International, Ltd Nanoparticulate formulations comprising hmg coa reductase inhibitor derivatives (statins), novel combinations thereof as well as manufacturing of these pharmaceutical compositions
JP2007230883A (ja) * 2006-02-28 2007-09-13 Kowa Co 新規なマラリア原虫類による感染症の予防及び／又は治療剤

Also Published As

Publication number Publication date
EP1894576A4 (en) 2010-04-21
WO2006132091A1 (ja) 2006-12-14
KR20080015789A (ko) 2008-02-20
CN101193656A (zh) 2008-06-04
PT1894576E (pt) 2011-07-29
CY1111768T1 (el) 2015-10-07
US20150272944A1 (en) 2015-10-01
US20090227610A1 (en) 2009-09-10
KR101258422B1 (ko) 2013-04-26
EP1894576A1 (en) 2008-03-05
JPWO2006132091A1 (ja) 2009-01-08
CN101193656B (zh) 2011-03-02
HK1111632A1 (en) 2008-08-15
EP1894576B1 (en) 2011-05-25
ES2362534T3 (es) 2011-07-07
JP4892477B2 (ja) 2012-03-07

Similar Documents

Publication Publication Date Title
PL2175273T3 (pl) Środek nadający kokumi
IL185906A0 (en) Composition
IL184421A0 (en) Fertilizer-compatible composition
GB0522658D0 (en) Composition
ZA200705932B (en) Fertilizer-compatible composition
GB0618435D0 (en) Composition
GB0507167D0 (en) Composition
GB0508250D0 (en) Composition
GB0506044D0 (en) Composition
EP1847249A4 (en) hair dye
ZA200707917B (en) Composition
EP1889660A4 (en) OZONE-GROWING AGENT
EP1927347A4 (en) MEANS TO REDUCE BITTERNESS
EP1947129A4 (en) PHOTORADIC AND PHOTOCYSTIC CURING COMPOSITION
PL1894576T3 (pl) Nowy środek do obniżania poziomu triglicerydów
GB0502341D0 (en) Composition
GB0513641D0 (en) Anti-egeing composition
GB0613762D0 (en) Slabline structure
GB0510286D0 (en) Composition
GB0512782D0 (en) Supports
GB0503644D0 (en) Catstep I
GB0520623D0 (en) Elevated structure
GB0523574D0 (en) Structure
GB0510598D0 (en) Composition
GB0509563D0 (en) Composition